Clinical Trial Update: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer [NA]

View source ↗

Summary

The trial evaluating stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University College, London | Conditions: Non-small Cell Lung Cancer | NA | Status: ACTIVE_NOT_RECRUITING